The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Open accessAbstract
Alarming data about increasing resistance to conventional antibiotics are reported, while at the same time the development of new antibiotics is stagnating. Skin and soft tissue infections (SSTIs) are mainly caused by the so called ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) which belong to the most recalcitrant bacteria and are resistant to almost all common antibiotics. S. aureus and P. aeruginosa are the most frequent pathogens isolated from chronic wounds and increasing resistance to topical antibiotics has become a major issue. Therefore, new treatment options are urgently needed. In recent years, research focused on the development of synthetic antimicrobial peptides (AMPs) with lower toxicity and improved activity compared to their endogenous counterparts. AMPs appear to be promising therapeutic options for the treatment of SSTIs and wounds as they show a broad spectrum of antimicrobial activity, low resistance rates and display pivotal immunomodulatory as well as wound healing promoting activities such as induction of cell migration and proliferation and angiogenesis. In this review, we evaluate the potential of AMPs for the treatment of bacterial SSTIs and wounds and provide an overview of the mechanisms of actions of AMPs that contribute to combat skin infections and to improve wound healing. Bacteria growing in biofilms are more resistant to conventional antibiotics than their planktonic counterparts due to limited biofilm penetration and distinct metabolic and physiological functions, and often result in chronification of infections and wounds. Thus, we further discuss the feasibility of AMPs as anti-biofilm agents. Finally, we highlight perspectives for future therapies and which issues remain to bring AMPs successfully to the market.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–221 of 221
Ventress, J. K., Partridge, L. J., Read, R. C., Cozens, D., MacNeil, S., & Monk, P. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160387 · Cited by 37
Dobson, A. J., Purves, J., & Rolff, J. (2014) · Evolutionary Applications · doi:10.1111/eva.12184 · Cited by 36
Local Inflammation Exacerbates the Severity of Staphylococcus aureus Skin Infection
Montgomery, C. P., Daniels, M. D., Zhao, F., Spellberg, B. J., Chong, A. S., & Daum, R. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069508 · Cited by 36
Wang, P., Nan, Y. H., Yang, S., Kang, S. W., Kim, Y., Park, I., Hahm, K., & Shin, S. Y. (2010) · Peptides · doi:10.1016/j.peptides.2010.03.032 · Cited by 36
Falciani, C., Lozzi, L., Scali, S., Brunetti, J., Bracci, L., & Pini, A. (2014) · Amino Acids · doi:10.1007/s00726-014-1686-2 · Cited by 35
Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r
Björn, C., Mahlapuu, M., Mattsby‐Baltzer, I., & Håkansson, J. (2016) · Peptides · doi:10.1016/j.peptides.2016.04.005 · Cited by 35
Antimicrobial Peptides and Skin: A Paradigm of Translational Medicine
Körting, H. C., Schöllmann, C., Stauss‐Grabo, M., & Schäfer‐Korting, M. (2012) · Skin Pharmacology and Physiology · doi:10.1159/000341990 · Cited by 34
Lack of new antiinfective agents: Passing into the pre-antibiotic age?
Brandenburg, K. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i3.71 · Cited by 30
Self-citationHost-defense peptides of the skin with therapeutic potential: From hagfish to human
Conlon, J. M. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.005 · Cited by 29
Ostorházi, E., Voros, E., Nemes-Nikodém, É., Pintér, D., Silló, P., Mayer, B., Wade, J. D., & Otvos, L. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.001 · Cited by 28
Antimicrobial efficacy of granulysin‐derived synthetic peptides in acne vulgaris
Lim, H., Chun, S., Soung, M., Kim, J. J., & Kim, S. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12756 · Cited by 26
Conlon, J. M., Abraham, B., Galadari, S., Knoop, F. C., Sonnevend, Á., & Pál, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.04.003 · Cited by 25
Ng, S. M. S., Teo, S. W., Yong, Y. E., et al. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13035 · Cited by 24
Anti-endotoxic and antibacterial effects of a dermal substitute coated with host defense peptides
Kasetty, G., Kalle, M., Mörgelin, M., Brune, J. C., & Schmidtchen, A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.111 · Cited by 22
Antimicrobial peptide KSL-W promotes gingival fibroblast healing properties in vitro
Park, H.-J., Salem, M., Semlali, A., Leung, K. P., & Rouabhia, M. (2017) · Peptides · doi:10.1016/j.peptides.2017.05.003 · Cited by 22
Seleem, M. N., Thangamani, S., Nepal, M., & Chmielewski, J. A. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s94505 · Cited by 18
Sperrhacke, M., Fischer, J., Wu, Z., Klünder, S., Sedláček, R., Schroeder, J. A., Meyer‐Hoffert, U., & Reiß, K. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.23 · Cited by 15
K1K8: an Hp1404-derived antibacterial peptide
Li, Z., Liu, G., Meng, L., Yu, W., Xu, X., Li, W., Wu, Y., & Cao, Z. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7395-x · Cited by 14
Emerging drugs for complicated skin and skin-structure infections
Mendoza, N., & Tyring, S. K. (2010) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2010.497486 · Cited by 9
Hauteigene Antibiotika: Wichtige Erkenntnisse über antimikrobielle Peptide für Klinik und Praxis
Cordes, J., Wittersheim, M., Harder, J., & Gläser, R. (2014) · Der Hautarzt · doi:10.1007/s00105-013-2638-6 · Cited by 9
Innate Immune Defense System of the Skin
Afshar, M., & Gallo, R. L. (2013) · Wiley eBooks · doi:10.1002/9781118644317.ch5 · Cited by 7
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
Antimicrobial peptides: mechanism of action, activity and clinical potential
Zhang, Q.-Y., Yan, Z.-B., Meng, Y.-M., Hong, X.-Y., Shao, G., Ma, J.-J., Cheng, X.-R., Liu, J., Kang, J., & Fu, C.-Y. (2021) · Military Medical Research · doi:10.1186/s40779-021-00343-2 · Cited by 1,065
Therapeutic strategies for enhancing angiogenesis in wound healing
Veith, A. P., Henderson, K., Spencer, A., Sligar, A. D., & Baker, A. B. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.010 · Cited by 1,021
The Dynamics of the Skin’s Immune System
Nguyen, A. V., & Soulika, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081811 · Cited by 694
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Metadata
- Authors
- Pfalzgraff, A., Brandenburg, K., & Weindl, G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-03-28
- Volume
- 9
- Pages
- 281-281
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2795098196
- Cited by
- 481
- References
- 221
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.